Delivery Order V797D50492-36C25924F0401
Award Date
6/25/24
Potential Completion Date
6/26/24
Potential Value
$23K
Federal Agency
Veterans Integrated Service Network 19
Ultimate Awardee
Takeda Pharmaceutical Company LIMITED
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Lexington, MA 02421, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm fixed-price delivery order to Takeda Pharmaceuticals America Inc., a subsidiary of Takeda Pharmaceutical Company LIMITED, for $22,375.80 to supply ADVATE vials. This order was placed against Takeda's Pharmaceuticals and Drugs GSA Schedule contract. Takeda Pharmaceuticals America Inc. is the prime contractor and has previously provided specialty pharmaceuticals, including treatments for hemophilia, immune...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 awarded Takeda Pharmaceuticals America Inc. a $27,067.50 firm fixed price delivery order for ADVATE vials to treat hemophilia. The delivery order was issued against Takeda's Pharmaceuticals and Drugs GSA Schedule contract with no set-aside designation applied. Takeda will provide the specialty biopharmaceutical products to support patient care programs at VA facilities in Lexington,...
This federal contract award is a delivery order for PHARMACY ADVATE ANTIHEMOPHILIC FACTOR, RECOMBINANT 2000UNT/VIL INJ, placed by the Department of Veterans Affairs (VA) under the Pharmaceuticals and Drugs General Services Administration (GSA) Schedule. The prime contractor is Takeda Pharmaceuticals America Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract has a ceiling value of $16,175.70 and no set-aside designation. This award represents a task order under a larger...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 awarded Takeda Pharmaceuticals America Inc. a $14,483.70 firm fixed price delivery order for pharmacy products under the company's Pharmaceuticals and Drugs GSA Schedule contract number FSS-61-IB. The delivery order, which does not have a set-aside designation, is for Vonvendi to support the agency's pharmacy programs and will be completed by December 11, 2023. Takeda Pharmaceuticals...
The Department of Justice Bureau of Prisons awarded a firm fixed price delivery order contract to Takeda Pharmaceuticals America Inc. to provide ADVATE and GAMMAGARD specialty pharmaceuticals. The contract, valued at $161,315.22, is issued against Takeda's Pharmaceuticals and Drugs General Services Administration (GSA) Schedule contract. Takeda Pharmaceuticals America Inc. is a subsidiary of the global biopharmaceutical company Takeda Pharmaceutical Company LIMITED. The contract does not have...
The Department of Veterans Affairs (VA) awarded a firm fixed-price delivery order contract to Takeda Pharmaceuticals America Inc., a subsidiary of Takeda Pharmaceutical Company LIMITED, for the supply of the specialty pharmaceutical TAKHZYRO. The contract has a potential value of $36,890.40 and a completion date of April 24, 2024. Takeda Pharmaceuticals America Inc. is a prime contractor that provides a range of pharmaceutical products, including those to treat hemophilia, immune disorders,...
The Department of Justice Bureau of Prisons Federal Correctional Institution Fort Worth awarded a firm fixed price delivery order to Takeda Pharmaceuticals America Inc., a subsidiary of Takeda Pharmaceutical Company Limited, for the supply of ADVATE, a specialty pharmaceutical product used to treat hemophilia. The $101,219.85 order was placed under Takeda's existing Pharmaceuticals and Drugs General Services Administration (GSA) Schedule contract, with no set-aside applied. Takeda...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm fixed-price delivery order to Takeda Pharmaceuticals America Inc. under the company's Pharmaceuticals and Drugs GSA Schedule contract. The $36,890.40 order is for the specialty pharmaceutical product TAKHZYRO 150MG ML SYRINGE 2ML PER SYRINGE, which is used to treat hereditary angioedema. The delivery order has an April 2024 completion date and will support patient care programs across the VA's Veterans...
The Department of Veterans Affairs Veterans Health Administration awarded Takeda Pharmaceuticals America Inc. a $17,884.44 firm fixed price delivery order against its Pharmaceuticals and Drugs GSA Schedule contract. Takeda will provide EMERGENCY FEIBA to VHA locations in Lexington, Massachusetts from November 2023 through February 2024. As the leading provider of healthcare services to veterans, VHA relies on contracts such as this one to ensure a steady supply of critical medicines for its...
This is a firm fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Takeda Pharmaceuticals America Inc., a subsidiary of Takeda Pharmaceutical Company LIMITED, a leading global biopharmaceutical company. The delivery order, valued at $129,841.55, is for the provision of CINRYZE C-1, a specialty pharmaceutical product, under the Pharmaceuticals and Drugs General Services Administration (GSA) Schedule contract. Takeda Pharmaceuticals America Inc. has an established...